This coverage index provides an overview of Kenya’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
78%
Blinding trachoma
12%
Intestinal worms
66%
Bilharzia
41%
River blindness
N/A
8.3 million people received treatment in Kenya in 2017 3.33 million people did not receive treatment in Kenya in 2017

Priorities for progress in Kenya

  • Kenya should urgently address the supply chain issues that are heavily impacting the treatment of trachoma in the country.
  • Further, it should work to build a strong preventive therapy programme with systematically high annual coverage across all of the five NTDs.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage increased from 60% in 2016 to 78% in 2017.

People needing treatment
3.87m
People receiving treatment
3.02m

Blinding trachoma

Treatment coverage decreased from 23% in 2016 to 12% in 2017.

People needing treatment
3.33m
People receiving treatment
0.4m

Intestinal worms

Treatment coverage increased from 60% in 2016 to 66% in 2017.

Pre-sch and school-aged children needing treatment
9.18m
Pre-school and school-aged children receiving treatment
6.06m

Bilharzia

Treatment coverage decreased from 42% in 2016 to 41% in 2017.

School-aged children needing treatment
1.37m
School-aged children receiving treatment
0.56m

River blindness

Kenya does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Kenya.